Tether Invests $200 Million in Blackrock Neurotech to Boost BCI Technology
Tether, the leading stablecoin provider famous for USDT, has recently disclosed a strategic investment in Blackrock Neurotech, a major player in brain-computer interface (BCI) technology and a competitor to Elon Musk's Neuralink.
In an official statement released yesterday, April 29, Tether highlighted its substantial $200 million investment through Tether Evo, its newly established venture arm. This move has stirred considerable interest in the cryptocurrency market, signaling Tether’s ambition to diversify into various sectors, including data, education, and energy.
The investment aims to strengthen Blackrock Neurotech, a global leader in neuroscience and neural prosthetics. With Tether’s significant backing, the stablecoin provider now holds a key stake in Blackrock Neurotech.
Established in 2008, Blackrock Neurotech has rapidly become a frontrunner in neuroscience and BCI technology, led by experts Dr. Florian Solzbacher and Marcus Gerhardt. Based in Salt Lake City, Utah, the company is dedicated to assisting millions worldwide facing paralysis and neurological disorders.
READ MORE: Apple Seeks AI Boost for iPhone Through Potential Partnerships
Tether’s move to expand its offerings is consistent with its investment in Blackrock Neurotech, aligning with its recent plans to diversify beyond stablecoins, as reported by CoinGape Media.
Earlier this month, Tether announced its intention to broaden its services into various sectors, including data, finance, energy, and education.
These developments mark a significant diversification for Tether, showcasing its evolution beyond stablecoins and reflecting a milestone in the global crypto space. As of now, Tether USDT has experienced a 22.62% increase in its 24-hour trading volume, reaching $46.84 billion.